When the most intractable problems in human health have stymied science for millennia, we can’t simply repeat the same approach and hope for better results. We partner with trailblazing scientists to co-found companies capable of solving some of the most persistent problems in human health. We’re tapping the brightest minds to imagine a healthier future.
2021
TandemAI is focused on lowering the barrier to entry to the most advanced tools in drug discovery.
2021
Full-Life Technologies is a fully integrated global nuclear health company seeking to own the entire value chain for radio-ligand production, research, development and commercialization and deliver clinical impact for patients.
Partner and Chief Investment Officer
Lanny Sun is a seasoned life science executive with more than a decade of experience and a strong track record in biotechnology.
Partner and Chief Operations Officer
Chris Borella has over 20 years of experience in drug discovery and development, almost exclusively at small and mid-sized biotech companies.
Partner and Chief People Officer
Andrea Brener is a seasoned human resources and talent acquisition professional with more than two decades of experience and a strong record in life sciences.
Partner
Josh Jiang is a seasoned professional with more than 16 years of experience and an established track record in healthcare investment banking, transactions, and finance and tax consulting.